Pharm Test 1 Flashcards
ADME stands for…..
Absorption
Distribution
Metabolism
Excretion
The 4 key physiological processes that govern movement of a drug in the body
T/F. A drug is not absorbed when given intravascularly
True
Name 3 factors that affect the rate and extent of drug absorption
Route of administration Availability of drug at site if absorption Local blood flow Physical barriers Physicochemical properties
T/ F. In the GIT divalent and trivalent cations inhibit absorption of fluoroquinolones and tetracyclines administered orally
True
Drugs that increase gastric pH ( antacids, omeprazole) inhibit the oral absorption of what type of drugs? A. Antibiotics B. Inhaled sedation C. Azole antifungals D. Antivirals
C
The process of drug absorption is important because it influences 4 fundamental events of pharmacological outcomes. Name those 4 fundamentals
- Onset of drug action
- Intensity of effect
- Extent of drug effect
- Adverse effects
Name some organs that are better protected than others
Testicles
Uterus
Eyes
Collies and their mdr stuff
What does MDR1 cause regarding drug transportation
It causes efflux of drugs. Therefore a mutation prevents efflux of drugs outside the cells
What are the 2 forms of drug elimination?
Bio transformation and excretion
What are some anatomical sites for bio transformation
Kidney Liver Lungs GI Blood vessels
T/F Drug interactions involving CYP enzymes are uncommon
False. They are common Either by inhibiting the enzyme or inducing the enzyme in phase 1 reactions
Which of the following does not cause a decrease activity of enzymes when it comes to bio transformation A. Co- administration of another drug B. Hepatic disease C. Nutritional deficits D. Age E. High body temperature
E- low body temperature effects this
T/F an inhibitor of an enzymatic system is more likely to lead to toxic effect than an inducer of enzymatic system
True
Inducers can lead to lower concentrations and less effectiveness of the drug while inhibitors can cause too high / toxic concentrations.
Which of the following is/ are dose dependent pharmacokinetic parameters? A. Tmax B. Cmax C. Clearance D. Bioavailability E. AUC F. Volume of drug distribution G. Half Life
B and E. Cmax and AUC
The rest are dose independent PK parameters
T/ F drug accumulation depends on the property of the drug
False. There are no drugs that aren’t cumulative (All drugs are cumulative)
Administration of drug every ____ or more half lives will result in little accumulation.
3
A smaller RDI results in _______ accumulation (differences between cmax and cmax ss) and ______ fluctuation (difference between cmax ss and cmin ss)
A. More, More
B. More, Less
C. Less, Less
D. Less, More
B ( better for a narrow therapeutic window)
A larger rdi is less accumulation and more fluctuation (better for a wide therapeutic window)
T/F. Combined effects of factors leading to inter individual variability are often unpredictable
True.
Physiologic
Pathological and pharmological interindividual effects
Trial and error approach to therapeutic drug monitoring is appropriate in what instances?
When response can be easily measured (iso)
Illnesses that are not serious/ do not need immediate resolution
Drugs with large therapeutic windows
Safe at high doses
TDM is useful in all but which of these cases? A. Wide therapeutic window B. Steep- dose response curve C. A difficult to detect end point D. Drugs with serious toxicity
A.
Narrow range
Name some factors that would characterize a patients as high risk for drug to drug interactions
Old Young Very sick Multiple diseases Chronic treatment Renal or liver impairments
Name some characteristics of a drug that could identify it as a high risk drug for DDIs
Narrow therapeutic windows
Enzyme inhibitors or inducers
What are the mechanisms of drug to drug interactions
Displacement of drug from binding site
Alteration of drug transporters
Name the ABCB 1 BLOCKERS
A. Itraconazole B. Cyclosporine C. Vincristine D. Vinblastine E. Rifampin F. Dexamethasone G. Chloramphenicol H. Clarithromycin I. Ivermectin J. Loperamide K. Acepromazine L. Verapamil
A itraconazole B cyclosporine G chloramphenicol H clarithromycin L verapamil
Name the ABCB 1 SUBSTRATE
A. Cortisol B. Cyclosporine C. Vincristine D. Vinblastine E. Doxorubicin F. Dexamethasone G. Mitoxantrone H. Clarithromycin I. Ivermectin J. Loperamide K. Digoxin L. Verapamil
A. Cortisol C. Vincristine D. Vinblastine E. Doxorubicin G. Mitoxantrone I. Ivermectin J. Loperamide K. Digoxin
Name the ABCB 1 INDUCERS
A. Itraconazole B. Cyclosporine C. Vincristine D. Vinblastine E. Rifampin F. Dexamethasone G. Chloramphenicol H. Clarithromycin I. Ivermectin J. Loperamide K. Acepromazine L. Verapamil
E. Rifampin
F. Dexamethasone
K. Acepromacine
T/F inhibition of metabolism does not require multiple doses over time
True.
Induction does though
CYP 450 BLOCKERS
A. Phenobarbital B. Phenytoin C. Quinidine D. Opioids E. Ketoconazole F. Enrofloxacin G. Chloranphenicol H. Barbiturics I. Propofol J. Erythromycin K. Fluoxetine L. Glucocorticoids
C. Quinidine E. Ketoconizole F. Enrofloxacin G. Chloranphenicol J. Erythromycin K. Fluoxetine
CYP 450 SUBSTRATES
A. Ketamine B. Propranolol C. Benzodiazepines D. Opioids E. Ketoconazole F. Carvedilol G. Chloranphenicol H. Barbiturics I. Propofol J. Cyclosporine K. Fluoxetine L. Atenolol
A. Ketamine B. Propranolol C. Benzodiazepines D. Opiods F. Carvedilol H. Barbiturics I. Propofol J. Cyclosporine L. Atenolol
CYP 450 INDUCERS
A. Phenobarbital B. Phenytoin C. Quinidine D. Opioids E. Ketoconazole F. Enrofloxacin G. Chloranphenicol H. Rifampin I. Propofol J. Erythromycin K. Fluoxetine L. Glucocorticoids
A. Phenobarbital
B. Phenytoin
H. Rifampin
L. Glucocorticoids
What is responsible for regulating/ enforcing laws related to drug use in vet med
FDA
Who/ what is responsible for safety and efficacy of nutritional supplements, compounded drugs and drugs used in an extra label fashion?
Vet
T/F. GFR affects drugs clearance, is affected by certain drugs and is estimated via a BUN/ creatinine.
True
Which of the following resorbs the most water and solute? A. Glomerulus B. Proximal Tubules C. Loop of henle D. Distal Tubule
B
65-85 % of total
Spillover or loss occurs here
The descending portion of the loop of henle is impermeable to (solutes/ water) while the ascending portion is impermeable to (solutes/ water)
Solutes. Water
ADH causes ______ to open
Aquaporins
Drug molecules are taken up by membrane ______ proteins and then deprive red the the lumen of the tubules
Transport
What are secreted by the organic acid transporters?
Loop diuretics
Furosemide
Thiazides diuretics
Acetazolamide
Name 2 reasons that furosemide would have a decreased efficacy
Patients with renal disease (limited delivery of diuretic to site of action)
Excess organic acids/anions (endogenous like keyoglutarate, or exogenous like NSAIDS) that compete with furosemide for tubular secretion
(Endogenous organic acids may accumulate during renal disease)
How do diuretics generally (primarily) accomplish increasing water excretion? A. Increase Na excretion B. Increase Na reabsorption C. Decrease Cl excretion D. Decrease Cl reabsorption
A
Along with alteration of elongation of K, H, Cl, HCO3 and altering renal hemodynamic (decreased blood flow to kidney)